LENSAR Reports First Quarter 2024 Results and Provides Business Update [Yahoo! Finance]
LENSAR, Inc. (LNSR)
Company Research
Source: Yahoo! Finance
ORLANDO, Fla., May 09, 2024 BUSINESS WIRE )--LENSAR, Inc. (Nasdaq: LNSR) ("LENSAR" or "the Company"), a global medical technology company focused on advanced femtosecond laser solutions for the treatment of cataracts, today announced financial results for the quarter ended March 31, 2024 and provided an update on key operational initiatives. "Recognition of ALLY's advantages, its ability to achieve higher efficiencies for surgeons and staff as well as better surgical outcomes for patients, allowed us to deliver continued 20%+ revenue growth in the first quarter of 2024. Total revenue for the quarter was $10.6 million, up 28% over the first quarter of 2023. Moreover, procedure volume grew by 23% in the U.S., our largest market and the only country where ALLY is currently marketed," said Nick Curtis, President and CEO of LENSAR. "More importantly, our U.S. procedure share continued to grow, increasing 1.5% in the first quarter from the fourth quarter of 2023, as reported by Market Sc
Show less
Read more
Impact Snapshot
Event Time:
LNSR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LNSR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LNSR alerts
High impacting LENSAR, Inc. news events
Weekly update
A roundup of the hottest topics
LNSR
News
- LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business Wire
- LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads ConferenceBusiness Wire
- LENSAR, Inc. (NASDAQ:LNSR) Just Reported, And Analysts Assigned A US$8.00 Price Target [Yahoo! Finance]Yahoo! Finance
- LENSAR First Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]Yahoo! Finance
- LENSAR Reports First Quarter 2024 Results and Provides Business UpdateBusiness Wire
LNSR
Sec Filings
- 5/13/24 - Form 8-K
- 5/9/24 - Form 4
- 5/9/24 - Form 4
- LNSR's page on the SEC website